Today CareRx Corp climbed above its 200-day moving average line and it closed above it, a long-term BULLISH signal.
It did so on more than 7 times average daily volume.
TradingView's technical analysis summary is BUY:
https://www.tradingview.com/symbols/TSX-CRRX/
This stock's average analyst rating is BUY and its price target is $7.75:
https://www.theglobeandmail.com/investing/markets/stocks/CRRX-T/research/
That is more than 69.78% higher than the current price of $4.27.
Lately, investment funds have been buying shares of this stock on a net basis:
https://www.morningstar.ca/ca/report/stocks/ownership.aspx?t=0P00005SDU&lang=en-CA
And so far this year, insiders have been buying this stock:
https://www.canadianinsider.com/node/7?menu_tickersearch=CRRX%2B%7C%2BCareRx
GLTA!
It did so on more than 7 times average daily volume.
TradingView's technical analysis summary is BUY:
https://www.tradingview.com/symbols/TSX-CRRX/
This stock's average analyst rating is BUY and its price target is $7.75:
https://www.theglobeandmail.com/investing/markets/stocks/CRRX-T/research/
That is more than 69.78% higher than the current price of $4.27.
Lately, investment funds have been buying shares of this stock on a net basis:
https://www.morningstar.ca/ca/report/stocks/ownership.aspx?t=0P00005SDU&lang=en-CA
And so far this year, insiders have been buying this stock:
https://www.canadianinsider.com/node/7?menu_tickersearch=CRRX%2B%7C%2BCareRx
GLTA!
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.